Literature DB >> 9333055

Antimicrobial susceptibility patterns of thermophilic Campylobacter spp. from humans, pigs, cattle, and broilers in Denmark.

F M Aarestrup1, E M Nielsen, M Madsen, J Engberg.   

Abstract

The MICs of 16 antimicrobial agents were determined for 202 Campylobacter jejuni isolates, 123 Campylobacter coli isolates, and 6 Campylobacter lari isolates from humans and food animals in Denmark. The C. jejuni isolates originated from humans (75), broilers (95), cattle (29), and pigs (3); the C. coli isolates originated from humans (7), broilers (17), and pigs (99); and the C. lari isolates originated from broilers (5) and cattle (1). All isolates were susceptible to apramycin, neomycin, and gentamicin. Only a few C. jejuni isolates were resistant to one or more antimicrobial agents. Resistance to tetracycline was more common among C. jejuni isolates from humans (11%) than among C. jejuni isolates from animals (0 to 2%). More resistance to streptomycin was found among C. jejuni isolates from cattle (10%) than among those from humans (4%) or broilers (1%). A greater proportion of C. coli than of C. jejuni isolates were resistant to the other antimicrobial agents tested. Isolates were in most cases either coresistant to tylosin, spiramycin, and erythromycin or susceptible to all three antibiotics. More macrolide-resistant isolates were observed among C. coli isolates from swine (79%) than among C. coli isolates from broilers (18%) and humans (14%). Twenty-four percent of C. coli isolates from pigs were resistant to enrofloxacin, whereas 29% of C. coli isolates from humans and none from broilers were resistant. More resistance to streptomycin was observed among C. coli isolates from swine (48%) than among C. coli isolates from broilers (6%) or humans (0%). The six C. lari isolates were susceptible to all antimicrobial agents except ampicillin and nalidixic acid. This study showed that antimicrobial resistance was found only at relatively low frequencies among C. jejuni and C. lari isolates. Among C. coli isolates, especially from swine, there was a high level of resistance to macrolides and streptomycin. Furthermore, this study showed differences in the resistance to antimicrobial agents among Campylobacter isolates of different origins.

Entities:  

Mesh:

Year:  1997        PMID: 9333055      PMCID: PMC164100     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Reproducibility of tolerance tests that are useful in the identification of campylobacteria.

Authors:  S L On; B Holmes
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

2.  Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults.

Authors:  L J Goodman; G M Trenholme; R L Kaplan; J Segreti; D Hines; R Petrak; J A Nelson; K W Mayer; W Landau; G W Parkhurst
Journal:  Arch Intern Med       Date:  1990-03

3.  Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine.

Authors:  H P Endtz; G J Ruijs; B van Klingeren; W H Jansen; T van der Reyden; R P Mouton
Journal:  J Antimicrob Chemother       Date:  1991-02       Impact factor: 5.790

4.  Antimicrobial susceptibility of Campylobacter jejuni, Campylobacter coli, and Campylobacter laridis from cats, dogs, pigs, and seagulls.

Authors:  C Kaneuchi; M Ashihara; Y Sugiyama; T Imaizumi
Journal:  Nihon Juigaku Zasshi       Date:  1988-06

5.  Observations made on strains of Campylobacter spp. isolated in 1989 in northern Italy.

Authors:  O Varoli; M Gatti; M T Montella; M La Placa
Journal:  Microbiologica       Date:  1991-01

6.  Treatment of traveler's diarrhea with ciprofloxacin and loperamide.

Authors:  B P Petruccelli; G S Murphy; J L Sanchez; S Walz; R DeFraites; J Gelnett; R L Haberberger; P Echeverria; D N Taylor
Journal:  J Infect Dis       Date:  1992-03       Impact factor: 5.226

7.  In vitro susceptibility of Campylobacter jejuni and Campylobacter coli isolated in Denmark to fourteen antimicrobial agents.

Authors:  J J Andreasen
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1987-06

8.  Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland.

Authors:  H Rautelin; O V Renkonen; T U Kosunen
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

9.  Prevalence, biotypes, plasmid profile and antimicrobial resistance of Campylobacter isolated from wild and domestic animals from northeast Portugal.

Authors:  J Cabrita; J Rodrigues; F Bragança; C Morgado; I Pires; A P Gonçalves
Journal:  J Appl Bacteriol       Date:  1992-10

10.  Isolation and antimicrobial susceptibility of Campylobacter coli and Campylobacter jejuni from slaughter hogs.

Authors:  H Hariharan; T Wright; J R Long
Journal:  Microbiologica       Date:  1990-01
View more
  28 in total

1.  Macrolide resistance in Campylobacter coli of animal origin in Denmark.

Authors:  L B Jensen; F M Aarestrup
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

2.  Antimicrobial susceptibilities of thermophilic Campylobacter from humans, swine, and chicken broilers.

Authors:  Evelyne Guévremont; Eric Nadeau; Marc Sirois; Sylvain Quessy
Journal:  Can J Vet Res       Date:  2006-04       Impact factor: 1.310

3.  Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998.

Authors:  Y Sáenz; M Zarazaga; M Lantero; M J Gastanares; F Baquero; C Torres
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

4.  Temporal prevalence of antimicrobial resistance in Campylobacter spp. from beef cattle in Alberta feedlots.

Authors:  G D Inglis; D W Morck; T A McAllister; T Entz; M E Olson; L J Yanke; R R Read
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

5.  Effects of subtherapeutic administration of antimicrobial agents to beef cattle on the prevalence of antimicrobial resistance in Campylobacter jejuni and Campylobacter hyointestinalis.

Authors:  G D Inglis; T A McAllister; H W Busz; L J Yanke; D W Morck; M E Olson; R R Read
Journal:  Appl Environ Microbiol       Date:  2005-07       Impact factor: 4.792

6.  Phenotypic and genotypic diversity of thermophilic Campylobacter spp. in commercial turkey flocks: a longitudinal study.

Authors:  Isaac P Kashoma; Anand Kumar; Yasser M Sanad; Wondwossen Gebreyes; Rudovick R Kazwala; Rebecca Garabed; Gireesh Rajashekara
Journal:  Foodborne Pathog Dis       Date:  2014-09-03       Impact factor: 3.171

7.  Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates.

Authors:  J Engberg; F M Aarestrup; D E Taylor; P Gerner-Smidt; I Nachamkin
Journal:  Emerg Infect Dis       Date:  2001 Jan-Feb       Impact factor: 6.883

8.  A Comparison between Hippurate Hydrolysis and Multiplex PCR for Differentiating Campylobacter coli and Campylobacter jejuni.

Authors:  Frederick Adzitey; Janet Corry
Journal:  Trop Life Sci Res       Date:  2011-05

9.  Activities of telithromycin, erythromycin, fluoroquinolones, and doxycycline against Campylobacter strains isolated from Finnish subjects.

Authors:  Daniela Schönberg-Norio; Marja-Liisa Hänninen; Marja-Leena Katila; Suvi-Sirkku Kaukoranta; Markku Koskela; Erkki Eerola; Jaakko Uksila; Sini Pajarre; Hilpi Rautelin
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

10.  Antimicrobial resistance in Campylobacter jejuni and Campylobacter coli strains isolated in 1991 and 2001-2002 from poultry and humans in Berlin, Germany.

Authors:  Petra Luber; Jutta Wagner; Helmut Hahn; Edda Bartelt
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.